AstraZeneca CEO says new Pfizer bid unlikely-Swedish daily DI
December 20, 2014 at 08:06 AM EST
STOCKHOLM, Dec 20 (Reuters) - U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday.